Search Medical Condition
Please enter condition
Please choose location

COPD (Chronic Obstructive Pulmonary Disease) Clinical Trials

A listing of COPD (Chronic Obstructive Pulmonary Disease) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (192) clinical trials

Dr. Craig LaForce and Dr. Karen Dunn are recruiting individuals 40 years and up who suffer from COPD, emphysema or Chronic bronchitis to participate in a research study, involving an investigational medication.

Phase N/A

An investigational study comparing Spiriva to an investigational nebulized medication with NO Chance of placebo

Phase N/A

Clinical research trial for people with moderate to severe COPD (Chronic Pulmonary Disease)

Phase N/A

If you are a current or former smoker and experience symptoms from COPD (also known as emphysema or chronic bronchitis) such as wheezing, coughing, breathlessness or chest tightness, you may qualify for one of our paid research studies.

Phase

ActivMed Practices & Research of Portsmouth NH is conducting a research study on COPD.

Phase N/A

Nearly 15 million Americans suffer from chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis. COPD makes it hard to breathe, and can also cause wheezing, coughing, and chest tightness. Right now, doctors at Columbus Regional Research Institute are accepting participants for a new COPD research study. The ...

Phase N/A

The ASCENT Study is a clinical research study evaluating a medication for patients diagnosed with COPD who also have a history of heart disease, stroke or other cardiovascular risk factors.

Phase

The purpose of the study is to determine if benralizumab reduces COPD exacerbation rate in patients with moderate to very severe COPD who are receiving standard of care therapies.

Phase N/A

A Randomized, Double-Blind, Multi-Center, Parallel Group Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 on COPD Exacerbations over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD. ClinicalTrials.gov identifier: NCT02465567 https://www.pearltherapeutics.com/pipeline-overview Study Flyer

Phase N/A

A Randomized, Double-Blind, Multi-Center, Parallel Group Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 on COPD Exacerbations over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD. ClinicalTrials.gov identifier: NCT02465567 https://www.pearltherapeutics.com/pipeline-overview

Phase N/A